Indegene Limited, a digital-first life sciences commercialization company, has announced the opening of a new center in London as part of its strategic expansion in Europe. The move aims to strengthen the company’s ability to support life sciences clients in the region by offering advanced consulting and commercialization solutions with an AI-first approach.
The London center will serve as a key hub for Indegene’s European clients, allowing them to modernize operations and enhance customer engagement. The company is also expanding its workforce in the region, focusing on consulting, data analytics, engineering, and customer experience.
“London is a vital hub for healthcare, technology, and business innovation, offering a strong talent pool. With this new center, we are positioned to drive innovation and help our clients improve their commercialization processes,” said Manish Gupta, Chairman and CEO of Indegene.
This expansion follows Indegene’s recent launch of a new entity in Spain and strengthens its existing presence in Europe, which includes centers in Germany, Ireland, and Switzerland. The company has also made strategic acquisitions in the region, including Trilogy Writing & Consulting GmbH and DT Consulting, further enhancing its capabilities in medical writing and healthcare consulting.
Indegene continues to work with top biopharma companies worldwide, leveraging digital expertise to optimize product development, market access, and patient engagement solutions.
